{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T21:47:32Z","timestamp":1768254452410,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s11845-024-03652-2","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T06:51:21Z","timestamp":1710831081000},"page":"1807-1815","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of oral naloxone on opioid-induced constipation in methadone maintenance treatment patients, a double-blind, placebo-control, clinical trial"],"prefix":"10.1007","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4104-7978","authenticated-orcid":false,"given":"Shaghayegh","family":"Akhgarandouz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0389-2270","authenticated-orcid":false,"given":"Mohammad","family":"Moshiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2800-9395","authenticated-orcid":false,"given":"Leila","family":"Etemad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6004-0344","authenticated-orcid":false,"given":"Bita","family":"Dadpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2698-176X","authenticated-orcid":false,"given":"Majid","family":"Khadem-Rezaiyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0184-1015","authenticated-orcid":false,"given":"Nasser","family":"Vahdati-Mashhadian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,19]]},"reference":[{"key":"3652_CR1","doi-asserted-by":"crossref","unstructured":"Chou R, Hartung D, Turner J et al (2020)\u00a0Opioid treatments for chronic pain, in (Comparative Effectiveness Review, No. 229). In: Chou R, Hartung D, Turner J (eds) Agency for Healthcare Research and Quality, US","DOI":"10.23970\/AHRQEPCCER229"},{"key":"3652_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000028921","volume":"101","author":"M Osowicka","year":"2022","unstructured":"Osowicka M, Janowiak P, Gorzewska A et al (2022) Inhaled opioids for cancer pain relief: a narrative review. Medicine 101:e28921","journal-title":"Medicine"},{"key":"3652_CR3","first-page":"V08190447","volume":"182","author":"TW Licht","year":"2020","unstructured":"Licht TW, Bache NJ, Bredahl C et al (2020) Opioider til kroniske nonmaligne smerter. Ugeskr L\u00e6ger 182:V08190447","journal-title":"Ugeskr L\u00e6ger"},{"key":"3652_CR4","unstructured":"United Nations Office on Drugs and Crime.,(2021) Drug market trends: Cannabis opiods, Booklet 3 World Drug Report 2021, ed. Division for Policy Analysis and Public Affairs., Vienna Austria: The United Nations Office on Drugs and Crime"},{"key":"3652_CR5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.14196\/mjiri.32.64","volume":"32","author":"B Damari","year":"2018","unstructured":"Damari B, Almadani H, Pishkuhi MA (2018) Iranian drug use survey in workplaces: a study protocol. Med J Islam Repub Iran 32:93","journal-title":"Med J Islam Repub Iran"},{"key":"3652_CR6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","volume":"70","author":"CL Mattson","year":"2021","unstructured":"Mattson CL, Tanz LJ, Quinn K et al (2021) Trends and geographic patterns in drug and synthetic opioid overdose deaths\u2014United States, 2013\u20132019. Morb Mortal Wkly Rep 70:202","journal-title":"Morb Mortal Wkly Rep"},{"key":"3652_CR7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jpainsymman.2020.08.015","volume":"61","author":"KF Jones","year":"2021","unstructured":"Jones KF, Fu MR, Merlin JS et al (2021) Exploring factors associated with long-term opioid therapy in cancer survivors: an integrative review. J Pain Symptom Manage 61:395\u2013415","journal-title":"J Pain Symptom Manage"},{"key":"3652_CR8","first-page":"897","volume":"3","author":"G Karimi","year":"2009","unstructured":"Karimi G, Moshiri M, Etemad L (2009) Review of cases of lead poisoning from opium abuse in Iran. Pharmacol online 3:897\u2013905","journal-title":"Pharmacol online"},{"key":"3652_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.587","volume":"5","author":"A Banaye Yazdipour","year":"2022","unstructured":"Banaye Yazdipour A, Moshiri M, Dadpour B et al (2022) The trend of top five types of poisonings in hospitalized patients based on ICD-10 in the northeast of Iran during 2012\u20132018: a cross-sectional study. Health Sci Rep 5:e587","journal-title":"Health Sci Rep"},{"key":"3652_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.32598\/ijt.14.1.59","volume":"14","author":"M Moshiri","year":"2020","unstructured":"Moshiri M, Hedjazi A, Rezazadeh-Shojaie SM et al (2020) Child death due to dermal opium application: a case report. Iranian J Toxicol 14:59\u201362","journal-title":"Iranian Journal of Toxicology"},{"key":"3652_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.34172\/ahj.2022.1336","volume":"14","author":"Y Ramazani","year":"2023","unstructured":"Ramazani Y, Nemati A, Moshiri M et al (2023) Gastric obstruction by opium packets: a case report. Addict Health 14:309\u2013311","journal-title":"Addict Health"},{"key":"3652_CR12","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/AJP.0000000000000852","volume":"36","author":"CE Argoff","year":"2020","unstructured":"Argoff CE (2020) Opioid-induced constipation: a review of health-related quality of life, patient burden, practical clinical considerations, and the impact of peripherally acting \u00b5-opioid receptor antagonists. Clin J Pain 36:716","journal-title":"Clin J Pain"},{"key":"3652_CR13","doi-asserted-by":"crossref","unstructured":"Saini HS, Alvi Z, Singh B et al (2020) Methylnaltrexone and naloxone for opioid-induced constipation in the critical care setting. Cureus 12","DOI":"10.7759\/cureus.6829"},{"key":"3652_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/MCG.0000000000000246","volume":"49","author":"J Gaertner","year":"2015","unstructured":"Gaertner J, Siemens W, Camilleri M et al (2015) Definitions and outcome measures of clinical trials regarding opioid-induced constipation: a systematic review. J Clin Gastroenterol 49:9\u201316","journal-title":"J Clin Gastroenterol"},{"key":"3652_CR15","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.pain.2004.09.019","volume":"112","author":"E Kalso","year":"2004","unstructured":"Kalso E, Edwards JE, Moore RA et al (2004) Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 112:372\u2013380","journal-title":"Pain"},{"key":"3652_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cger.2020.08.007","volume":"37","author":"S Lucak","year":"2021","unstructured":"Lucak S, Lunsford TN, Harris LA (2021) Evaluation and treatment of constipation in the geriatric population. Clin Geriatr Med 37:85\u2013102","journal-title":"Clin Geriatr Med"},{"key":"3652_CR17","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.cgh.2018.01.021","volume":"16","author":"J Nee","year":"2018","unstructured":"Nee J, Zakari M, Sugarman MA et al (2018) Efficacy of treatments for opioid-induced constipation: systematic review and meta-analysis. Clin Gastroenterol Hepatol 16:1569\u20131584","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3652_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/apt.15791","volume":"52","author":"P Vijayvargiya","year":"2020","unstructured":"Vijayvargiya P, Camilleri M, Vijayvargiya P et al (2020) Systematic review with meta-analysis: efficacy and safety of treatments for opioid-induced constipation. Aliment Pharmacol Ther 52:37\u201353","journal-title":"Aliment Pharmacol Ther"},{"key":"3652_CR19","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.jcrc.2014.04.005","volume":"29","author":"CM Gibson","year":"2014","unstructured":"Gibson CM, Pass SE (2014) Enteral naloxone for the treatment of opioid-induced constipation in the medical intensive care unit. J Crit Care 29:803\u2013807","journal-title":"J Crit Care"},{"key":"3652_CR20","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1001\/jama.283.3.367","volume":"283","author":"C-S Yuan","year":"2000","unstructured":"Yuan C-S, Foss JF, O\u2019Connor M et al (2000) Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial. JAMA 283:367\u2013372","journal-title":"JAMA"},{"key":"3652_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0924-9338(15)31469-3","volume":"30","author":"A Samokhvalov","year":"2015","unstructured":"Samokhvalov A, Sproule B, Selby P et al (2015) Oral naloxone for methadone-induced constipation: preliminary results of a randomized placebo-controlled trial. Eur Psychiatry 30:1\u20131","journal-title":"Eur Psychiatry"},{"key":"3652_CR22","doi-asserted-by":"crossref","unstructured":"Samokhvalov, AV Rehm J (2015), Opioid-induced constipation reversal in response to placebo in a patient with a history of IBS receiving methadone maintenance therapy. BMJ Case Rep 2015","DOI":"10.1136\/bcr-2015-211954"},{"key":"3652_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13561-016-0091-9","volume":"6","author":"AJ Hatswell","year":"2016","unstructured":"Hatswell AJ, Vegter S (2016) Measuring quality of life in opioid-induced constipation: mapping EQ-5D-3 L and PAC-QOL. Health Econ Rev 6:14","journal-title":"Health Econ Rev"},{"key":"3652_CR24","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1517\/14656560903037168","volume":"10","author":"AL Stotts","year":"2009","unstructured":"Stotts AL, Dodrill CL, Kosten TR (2009) Opioid dependence treatment: options in pharmacotherapy. Expert Opin Pharmacother 10:1727\u20131740","journal-title":"Expert Opin Pharmacother"},{"key":"3652_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ejpain.2005.03.008","volume":"10","author":"R Slappendel","year":"2006","unstructured":"Slappendel R, Simpson K, Dubois D et al (2006) Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain. Eur J Pain 10:209\u2013217","journal-title":"Eur J Pain"},{"key":"3652_CR26","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/BF02056950","volume":"39","author":"F Agachan","year":"1996","unstructured":"Agachan F, Chen T, Pfeifer J et al (1996) A constipation scoring system to simplify evaluation and management of constipated patients. Dis Colon Rectum 39:681\u2013685","journal-title":"Dis Colon Rectum"},{"key":"3652_CR27","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/apt.14349","volume":"46","author":"Y Yiannakou","year":"2017","unstructured":"Yiannakou Y, Tack J, Piessevaux H et al (2017) The PAC-SYM questionnaire for chronic constipation: defining the minimal important difference. Aliment Pharmacol Ther 46:1103\u20131111","journal-title":"Aliment Pharmacol Ther"},{"key":"3652_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1177\/0269216311418869","volume":"26","author":"SH Ahmedzai","year":"2012","unstructured":"Ahmedzai SH, Nauck F, Bar-Sela G et al (2012) A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone\/naloxone prolonged-release tablets in patients with moderate\/severe, chronic cancer pain. Palliat Med 26:50\u201360","journal-title":"Palliat Med"},{"key":"3652_CR29","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2165\/00003495-200363070-00003","volume":"63","author":"A Kurz","year":"2003","unstructured":"Kurz A, Sessler DI (2003) Opioid-induced bowel dysfunction. Drugs 63:649\u2013671","journal-title":"Drugs"},{"key":"3652_CR30","first-page":"100768","volume":"33","author":"MZ Bidary","year":"2021","unstructured":"Bidary MZ, Sahranavard M, Rezayat AA et al (2021) Opium as a carcinogen: a systematic review and meta-analysis. E Clin Med 33","journal-title":"E Clin Med"},{"key":"3652_CR31","first-page":"40","volume":"6","author":"M Sarbaz","year":"2019","unstructured":"Sarbaz M, Kimiafar K, Khadem-Rezaiyan M et al (2019) Medical and surgical complications in three tertiary hospitals in the northeast of Iran: a multicenter study. Rev Clin Med 6:40\u201344","journal-title":"Reviews in Clinical Medicine"},{"key":"3652_CR32","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jpainsymman.2007.03.015","volume":"35","author":"M Noble","year":"2008","unstructured":"Noble M, Tregear SJ, Treadwell JR et al (2008) Long-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safety. J Pain Symptom Manage 35:214\u2013228","journal-title":"J Pain Symptom Manage"},{"key":"3652_CR33","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/clpt.1992.106","volume":"52","author":"JA Culpepper-Morgan","year":"1992","unstructured":"Culpepper-Morgan JA, Inturrisi CE, Portenoy RK et al (1992) Treatment of opioid-induced constipation with oral naloxone: a pilot study. Clin Pharmacol Ther 52:90\u201395","journal-title":"Clin Pharmacol Ther"},{"key":"3652_CR34","first-page":"86","volume":"7","author":"WVR Vieweg","year":"2005","unstructured":"Vieweg WVR, Lipps WFC, Fernandez A (2005) Opioids and methadone equivalents for clinicians. Prim Care Companion J Clin Psychiatry 7:86","journal-title":"Primary care companion to the Journal of clinical psychiatry"},{"key":"3652_CR35","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1136\/bmjspcare-2020-002387","volume":"11","author":"M Olmo","year":"2021","unstructured":"Olmo M, Gonz\u00e1lez-Barboteo J, Moreno-Alonso D et al (2021) Acute opioid withdrawal syndrome from naloxone\/naloxegol interaction. BMJ Support Palliat Care 11:408\u2013410","journal-title":"BMJ Support Palliat Care"},{"key":"3652_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0304-3959(99)00185-2","volume":"84","author":"W Meissner","year":"2000","unstructured":"Meissner W, Schmidt U, Hartmann M et al (2000) Oral naloxone reverses opioid-associated constipation. Pain 84:105\u2013109","journal-title":"Pain"},{"key":"3652_CR37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0885-3924(01)00369-4","volume":"23","author":"M Liu","year":"2002","unstructured":"Liu M, Wittbrodt E (2002) Low-dose oral naloxone reverses opioid-induced constipation and analgesia. J Pain Symptom Manage 23:48\u201353","journal-title":"J Pain Symptom Manage"},{"key":"3652_CR38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41386-022-01416-z","volume":"48","author":"M Tr\u00f8stheim","year":"2023","unstructured":"Tr\u00f8stheim M, Eikemo M, Haaker J et al (2023) Opioid antagonism in humans: a primer on optimal dose and timing for central mu-opioid receptor blockade. Neuropsychopharmacology 48:299\u2013307","journal-title":"Neuropsychopharmacology"},{"key":"3652_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2024.209307","volume":"160","author":"M Moshiri","year":"2024","unstructured":"Moshiri M, Chaeideh B, Ebrahimi M et al (2024) Buprenorphine induced opioid withdrawal syndrome relieved by adjunctive magnesium: a clinical trial. J Subst Use Addict Treat 160:209307","journal-title":"J Subst Use Addict Treat"},{"key":"3652_CR40","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3109\/15563650.2015.1060486","volume":"53","author":"A Wong","year":"2015","unstructured":"Wong A, Macleod D, Robinson J et al (2015) Oxycodone\/naloxone preparation can cause acute withdrawal symptoms when misused parenterally or taken orally. Clin Toxicol (Phila) 53:815\u2013818","journal-title":"Clin Toxicol (Phila)"},{"key":"3652_CR41","first-page":"18","volume":"26","author":"S-I Go","year":"2023","unstructured":"Go S-I, Kim JH, Kang JH (2023) Treatment of opioid withdrawal syndrome triggered by oxycodone\/naloxone with dexmedetomidine. J Hosp Palliat Care 26:18\u201321","journal-title":"Journal of Hospice and Palliative Care"},{"key":"3652_CR42","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s40199-021-00407-7","volume":"29","author":"M Vahabzadeh","year":"2021","unstructured":"Vahabzadeh M, Balali-Mood M, Banagozar Mohammadi A et al (2021) Efficacy and expenses of succimer vs. d-penicillamine plus garlic in the treatment of lead poisoning: a retrospective cross-sectional study. Daru 29:477\u2013481","journal-title":"Daru"},{"key":"3652_CR43","doi-asserted-by":"publisher","first-page":"526","DOI":"10.5812\/ircmj.4557","volume":"15","author":"B Dadpour","year":"2013","unstructured":"Dadpour B, Mehrpour O, Etemad L et al (2013) Lead poisoning-induced hypertensive crisis managed by prazosin: a case report. Iran Red Crescent Med J 15:526\u2013528","journal-title":"Iran Red Crescent Med J"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-024-03652-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-024-03652-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-024-03652-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T10:09:50Z","timestamp":1722506990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-024-03652-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["3652"],"URL":"https:\/\/doi.org\/10.1007\/s11845-024-03652-2","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,19]]},"assertion":[{"value":"19 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}